Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen (PSA) testing for diagnosing prostate cancer led to a surge in the number of prostate cancer diagnoses. We explore the trends in recommendations and new innovations in adjunctive testing for prostate cancer screening.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urolonc.2024.06.022 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!